April 06, 2023 at 10:36PM FDA CBER Office of Therapeutic Products (OTP) Advanced Manufacturing and Analytical Technologies (AMAT) for Regenerative Medicine Therapies (RMT) Workshop - 03/14/2023

The FDA’s Center for Biologics Evaluation and Research (CBER) Office of Therapeutic Products (OTP) is hosting a virtual Workshop with cell and gene therapy stakeholders to discuss innovative manufacturing technologies and alternative analytical testing methods in the manufacture of cell therapy, gene therapy and tissue engineered medical products.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/HpZXtEW